Semmelweis University, Budapest
Th1 cell response for Hsp60 AA437-460 is more prominent in type 1 diabetes patients
Published in Pharma Law Weekly, January 10th, 2006
According to a study from Hungary, "Type 1 diabetes mellitus (T1) is considered to be an immune mediated disease. Based on previous findings it might be suggested that heat shock protein 60 (Hsp60) could be involved in the mediation of the development of the disease. Furthermore a bias toward Th1 immune response was observed in T1D patients where the level of Th1 cytokines was elevated, while the level of Th2 was decreased."
A. Szebeni and colleagues at Semmelweis University proposed "[t]o determine Th1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-01-10)
More Articles from Pharma Law Weekly
- Alexza Pharmaceuticals, Inc.
Inhaled drug developer expands executive management team - Cochlear Americas
Medicare coverage announced for Baha Hearing System - CollaGenex Pharmaceuticals, Inc.
Dermatology company to acquire SansRosa Pharmaceutical Development, Inc. - Delcath Systems, Inc.
Medical technology company receives additional U.S. patent for cancer treatment system - End-of-Life Issues
Caregivers perceive the need greater access to ICU treatment and bioethics for end-of-life care - Medicare
Cigna and Longs Drugs team up to comarket Cignature Rx Medicare prescription drug plan - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
